.. raw:: html

    The main objective of the biologics supply chain is to guarantee supply continuity. Product shortages can endanger patientsâ€™ lives and impact a company&#8217;s market share. In addition, the lengthy regulatory approval process in this industry prolongs the time companies need to create new manufacturing capacity. Every part of the process is subject to stringent regulation, [&#8230;]
